Nadine Parker is a Researcher at the Centre for Precision Psychiatry within the Faculty of Medicine at the University of Oslo. She is affiliated with Oslo University Hospital HF - Ullevål, Section for Precision Psychiatry, where she conducts cutting-edge research at the intersection of psychiatric genetics, neuroimaging, and precision medicine. Her work primarily focuses on understanding the genetic architecture of mental health disorders and their biological underpinnings. Dr. Parker's research interests center on psychiatric genetics, neuroimaging biomarkers, and precision psychiatry approaches. Her work explores the genetic overlap between various mental health conditions including depression, schizophrenia, bipolar disorder, and substance use disorders. She investigates how these disorders relate to physiological markers like white blood cell counts, inflammatory markers, and brain structure. Her research employs advanced genomic techniques including genome-wide association studies, polygenic risk scoring, and cross-disorder pleiotropy analysis to uncover shared biological mechanisms. Her publication record shows a strong focus on genetic architecture of psychiatric disorders, with numerous high-impact publications in journals like Nature Communications, Biological Psychiatry, and Molecular Psychiatry. Her work often examines how mental health conditions intersect with immune function, metabolic processes, and brain structure. A recurring theme across her publications is the identification of shared genetic mechanisms across seemingly distinct disorders, suggesting common biological pathways that could inform new treatment approaches. Dr. Parker is an active collaborator within the precision psychiatry research community, frequently working with colleagues including Guy Hindley, Alexey Shadrin, and other researchers at the University of Oslo. Her research is supported by institutional resources at Oslo University Hospital and likely external funding sources given the scale of her collaborative projects involving large datasets and international consortia. She is part of the Precision Psychiatry research group at Oslo University Hospital, which focuses on developing more targeted approaches to psychiatric diagnosis and treatment through integration of genetic, neuroimaging, and clinical data. This group works at the forefront of translating genetic discoveries into clinically actionable insights for mental health care.








